Stay updated on Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.

Latest updates to the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a recruitment status note 'No longer looking for participants,' signaling that enrollment is closed. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates label formatting (Intervention/Treatment), while updating the revision tag to v3.6.0 and removing the older v3.5.5 tag.SummaryDifference0.1%

- Check10 days agoChange DetectedLocations were expanded to 189 sites worldwide with new hospitals listed (e.g., Weston Park Hospital in Sheffield; Leicester Royal Infirmary; Hospital Universitario 12 de Octubre in Madrid). The page now shows 'Results Posted' with the date 2026-06-03, indicating updated results availability.SummaryDifference3%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.5.4 was added, replacing Revision: v3.5.3. This indicates a metadata-level update to the study record rather than any substantive changes to the study content.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov release revision, changing the displayed version from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Abbotsford, British Columbia as a study location and updated the status to 'Results Submitted' while removing the previous 'No Results Posted' status.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab vs Durvalumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab vs Durvalumab in NSCLC Clinical Trial page.